Mattern MR - Search Results

1

Ubiquitin-based anticancer therapy: carpet bombing with proteasome inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitors.

Mattern MR, Wu J, Nicholson B. Mattern MR, et al. Biochim Biophys Acta. 2012 Nov;1823(11):2014-21. doi: 10.1016/j.bbamcr.2012.05.005. Epub 2012 May 17. Biochim Biophys Acta. 2012. PMID: 22610084 Free PMC article.

2

Deubiquitinating enzymes as novel anticancer targets.

Nicholson B, Marblestone JG, Butt TR, Mattern MR. Nicholson B, et al. Among authors: mattern mr. Future Oncol. 2007 Apr;3(2):191-9. doi: 10.2217/14796694.3.2.191. Future Oncol. 2007. PMID: 17381419 Free PMC article. Review.

3

Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities.

Nicholson B, Leach CA, Goldenberg SJ, Francis DM, Kodrasov MP, Tian X, Shanks J, Sterner DE, Bernal A, Mattern MR, Wilkinson KD, Butt TR. Nicholson B, et al. Among authors: mattern mr. Protein Sci. 2008 Jun;17(6):1035-43. doi: 10.1110/ps.083450408. Epub 2008 Apr 18. Protein Sci. 2008. PMID: 18424514 Free PMC article.

4

Strategies for the identification of novel inhibitors of deubiquitinating enzymes.

Goldenberg SJ, McDermott JL, Butt TR, Mattern MR, Nicholson B. Goldenberg SJ, et al. Among authors: mattern mr. Biochem Soc Trans. 2008 Oct;36(Pt 5):828-32. doi: 10.1042/BST0360828. Biochem Soc Trans. 2008. PMID: 18793145 Free PMC article. Review.

5

Detection and characterization of SUMO protease activity using a sensitive enzyme-based reporter assay.

Leach CA, Tian X, Mattern MR, Nicholson B. Leach CA, et al. Among authors: mattern mr. Methods Mol Biol. 2009;497:269-81. doi: 10.1007/978-1-59745-566-4_18. Methods Mol Biol. 2009. PMID: 19107424 Review.

6

Strategies for the identification of ubiquitin ligase inhibitors.

Goldenberg SJ, Marblestone JG, Mattern MR, Nicholson B. Goldenberg SJ, et al. Among authors: mattern mr. Biochem Soc Trans. 2010 Feb;38(Pt 1):132-6. doi: 10.1042/BST0380132. Biochem Soc Trans. 2010. PMID: 20074047 Free PMC article. Review.

7

Novel approach for characterizing ubiquitin E3 ligase function.

Marblestone JG, Suresh Kumar KG, Eddins MJ, Leach CA, Sterner DE, Mattern MR, Nicholson B. Marblestone JG, et al. Among authors: mattern mr. J Biomol Screen. 2010 Dec;15(10):1220-8. doi: 10.1177/1087057110380456. Epub 2010 Sep 23. J Biomol Screen. 2010. PMID: 20864734

8

Characterization of selective ubiquitin and ubiquitin-like protease inhibitors using a fluorescence-based multiplex assay format.

Tian X, Isamiddinova NS, Peroutka RJ, Goldenberg SJ, Mattern MR, Nicholson B, Leach C. Tian X, et al. Among authors: mattern mr. Assay Drug Dev Technol. 2011 Apr;9(2):165-73. doi: 10.1089/adt.2010.0317. Epub 2010 Dec 6. Assay Drug Dev Technol. 2011. PMID: 21133675 Free PMC article.

9

Targeting the ubiquitin E3 ligase MuRF1 to inhibit muscle atrophy.

Eddins MJ, Marblestone JG, Suresh Kumar KG, Leach CA, Sterner DE, Mattern MR, Nicholson B. Eddins MJ, et al. Among authors: mattern mr. Cell Biochem Biophys. 2011 Jun;60(1-2):113-8. doi: 10.1007/s12013-011-9175-7. Cell Biochem Biophys. 2011. PMID: 21448668

10

Analysis of ubiquitin E3 ligase activity using selective polyubiquitin binding proteins.

Marblestone JG, Larocque JP, Mattern MR, Leach CA. Marblestone JG, et al. Among authors: mattern mr. Biochim Biophys Acta. 2012 Nov;1823(11):2094-7. doi: 10.1016/j.bbamcr.2012.06.013. Epub 2012 Jun 18. Biochim Biophys Acta. 2012. PMID: 22721718 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page